INVESTOR AB
CIK 889232 · View on SEC EDGAR ↗
- Portfolio value
- $14.4B
- Positions
- 7
- As of
- June 30, 2026
Portfolio value QoQ: -4.8% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 2
- Effective number of positions
- 1.8
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.01% Est. buys $5,310,073 · sells $2,122,598
Median holding: 2.0 quarters Tracked Q4 2024–Q2 2026 · 26.9% still held
- New positions
- 1
- Increased
- 2
- Decreased
- 0
- Closed
- 4
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Performance vs S&P 500
Annualized: +4.1% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 100.0% · Options excluded: 0.0%
Sector breakdown
Full portfolio 7 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| AZN AstraZeneca PLC - American Depositary Shares | $9,782,080,532 | 67.92% | 51,587,810 | $-392,067,356 | |||
| NDAQ Nasdaq, Inc. - Common Stock | $4,606,178,375 | 31.98% | 58,439,208 | $-326,552,798 | Up ×2 | ||
| MDWD MediWound Ltd. - Ordinary Shares | $12,819,767 | 0.09% | 872,093 | $-1,229,651 | |||
| CLBT Cellebrite DI Ltd. - Ordinary Shares | $1,095,000 | 0.01% | 75,000 | $337,100 | Up ×1 | ||
| MU Micron Technology, Inc. - Common Stock | $542,516 | 0.00% | 470 | Up ×1 | |||
| VZ Verizon Communications Inc. Common Stock | $478,442 | 0.00% | 11,300 | $-88,818 | |||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $211,714 | 0.00% | 3,700 | $2,701 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| MU | $542,516 | 470 | 0.00% |
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| MCHP | Dec. 31, 2025 | 25,000 | $1,605,500 | 19.6% |
| TER | Dec. 31, 2025 | 9,000 | $1,238,760 | 95.4% |
| COF | March 31, 2026 | 5,000 | $1,211,800 | 17.1% |
| CHKP | March 31, 2026 | 5,000 | $927,800 | -7.1% |
| TIGO | Sept. 30, 2025 | 20,781 | $778,664 | 85.4% |
| CDNS | Sept. 30, 2025 | 2,500 | $770,375 | -10.2% |
| CLBT | Dec. 31, 2025 | 40,000 | $741,200 | -38.2% |
| COHR | June 30, 2026 | 3,000 | $714,630 | -28.9% |
| CCL | March 31, 2026 | 21,000 | $641,340 | 0.4% |
| KYIV | June 30, 2026 | 59,402 | $601,148 | -20.7% |
| ORCL | Dec. 31, 2025 | 2,000 | $562,480 | -26.9% |
| CRSR | June 30, 2026 | 99,711 | $553,396 | 14.8% |
| COHR | Sept. 30, 2025 | 6,000 | $535,260 | 160.3% |
| BLKXXXX | March 31, 2025 | 480 | $492,053 | No longer tracked |
| BLK | June 30, 2025 | 480 | $454,310 | 9.8% |
| KYIV | Dec. 31, 2025 | 35,000 | $437,500 | -1.2% |
| QBTS | March 31, 2026 | 15,000 | $392,250 | No longer tracked |
| GTES | Sept. 30, 2025 | 15,000 | $345,450 | 4.3% |
| ICE | June 30, 2025 | 1,700 | $293,250 | -14.1% |
| WHR | June 30, 2026 | 4,700 | $253,424 | 2.5% |
| SSNC | March 31, 2026 | 2,500 | $218,550 | 22.2% |